
# Turing – Roche Strategic Partnership Expert Advisory Panel - Team Charter

#### **Turing-Roche Strategic Partnership North Star:**

To develop methodology to enable the generation of insights to better understand patient and disease heterogeneity and its relevance to clinical outcomes at an unprecedented level of precision in order to improve clinical care.


#### **Expert Advisory Panel Team Purpose:**

To share and discuss ideas, advanced analytics challenges and potential projects and solutions between the Turing and Roche, as well as identifying potential projects / areas of interest to be taken to the Joint Steering Committee (JSC).


#### **Scope:**

**_In_**

- Generation of ideas for research areas and proposal to the JSC as potential research opportunities for the partnership

- Decision making on research areas to propose to the JSC

- Knowledge sharing and identifying areas of join interest for Roche and Turing

 - Connecting the partnership with relevant colleagues at your institution and beyond

- Review of proposed and on-going projects within the partnership

- Engagement with activities e.g. workshops within the partnership

**_Out_**

-  Decision making on research areas to pursue within the partnership (these decisions will be made by the JSC).

**Success would look like:**

A scientifically strong and diverse set of projects within the partnership taking us towards our North Star. 

Strong scientific relationships between Roche and the Turing.


### **Partnership Expectations of the team:**

##### General

The Turing-Roche partnership is committed to working together in a mutually respectful, collaborative and inclusive environment. We value the involvement of everyone in the community. We are committed to creating a friendly and respectful environment to best enable contributions from all members of our fast paced and distributed teams. All participants in our events/meetings and online communications are expected to show respect and courtesy to others at all times.

Any potential conflicts of interest should be disclosed to the partnership team as early as possible.

If you have concerns at any time regarding the above you may contact Vicky Hellon at vhellon@turing.ac.uk or Michelle O’Gorman at michelle.ogorman@roche.com


##### Duration & Time Commitment:


* Timeframe  - 12 months @5% FTE
* 3 – 4 ( 2hr) meetings/year
* Adhoc meetings to discuss specific topics
* Review of proposed and on-going projects within the partnership
* Pro-active engagement in activities within the partnership_

##### Ways of Working:

* Meeting platforms and collaboration tools of choice
  * Meetings - Zoom
  * Brainstorming – Jamboard (Google whiteboard)
  * Between meetings chat - Slack
https://join.slack.com/t/turingroche/shared_invite/zt-y5bnwynr-bN8gBb5g9c_dFHrnMggkjw

* For ad-hoc or informal meetings, please reach out to Vicky Hellon who can help facilitate timings and use of collaboration tools.


##### Team requirements to ensure success:

* Understand Roche areas of interest
* Understand datasets currently used by and of interest to Roche
* Understand the roadmap the partnership wants to take and potential deliverables/outputs along the way

**Team Membership:**

<table>
  <tr>
   <td>Team Member
   </td>
   <td>Institution
   </td>
   <td>Strength/Interests/Roles
  </tr>
  <tr>
   <td>Prof. Alejandro Frangi
   </td>
   <td>Leeds
   </td>
   <td>Imaging
  </tr>
  <tr>
   <td>Dr. Florian Markowetz
   </td>
   <td>CRUK
   </td>
   <td>Computational Biology
  </tr>
  <tr>
   <td>Prof. Michael Barnes
   </td>
   <td>QMUL
   </td>
   <td>Bioinformatics
  <tr>
   <td>Prof. Heather Harrington
   </td>
   <td>Oxford
   </td>
   <td>Systems Biology
  <tr>
   <td>Prof. Zoe Kourtzi
   </td>
   <td>Cambridge
   </td>
   <td>Psychology & Neuroscience
  </tr>
  <tr>
   <td>Prof. Chris Holmes
   </td>
   <td>The Alan Turing Institute
   </td>
   <td>Statistics, Causal inference, Machine learning
   </tr>
  <tr>
   <td>Prof. Ben MacArthur
   </td>
   <td>The Alan Turing Institute
   </td>
   <td>Quantitative Biomedicine
  <tr>
   <td>Chris Harbron
   </td>
   <td>Roche
   </td>
   <td>Expert Statistical Scientist
  </tr>
  <tr>
   <td>Ryan Copping
   </td>
   <td>Roche
   </td>
   <td>Global Head Data Science Acceleration
  </tr>
  <tr>
   <td>Astrid Kiermaier
   </td>
   <td>Roche
   </td>
   <td>Data and Analytics - Early stage product development
  <tr>
   <td>Gunther Jansen
   </td>
   <td>Roche
   </td>
   <td>Data Analytics and Imaging
   <tr>
   <td>Markus Bundschus
   </td>
   <td>Roche
   </td>
   <td>Data Science Technologies
   <tr>
   <td>Dan Ruderman
   </td>
   <td>Roche
   </td>
   <td>Digital Pathology
  </tr>
  <tr>
   <td>Adam Knott
   </td>
   <td>Roche
   </td>
   <td>Clinical Development
  </tr>
</table>

